D'Alfonso S, Barizzone N, Giordano M, Chiocchetti A, Magnani C, Castelli L, Indelicato M, Giacopelli F, Marchini M, Scorza R, Danieli M G, Cappelli M, Migliaresi S, Bigliardo B, Sabbadini M G, Baldissera E, Galeazzi M, Sebastiani G D, Minisola G, Ravazzolo R, Dianzani U, Momigliano-Richiardi P
Department of Medical Sciences and IRCAD, University of Eastern Piedmont, Novara, Italy.
Arthritis Rheum. 2005 Feb;52(2):539-47. doi: 10.1002/art.20808.
To test the association of osteopontin (OPN) polymorphisms with systemic lupus erythematosus (SLE).
The coding 5' and 3' flanking regions of the OPN gene were scanned for polymorphisms by denaturing high-performance liquid chromatography. A case-control association study was performed in 394 Italian SLE patients and 479 matched controls. OPN serum levels were determined by enzyme-linked immunosorbent assay in 40 patients and 124 controls, and the mean levels were compared between the different OPN genotypes.
Among the 13 detected single-nucleotide polymorphisms (SNPs), alleles -156G (frequency 0.714 versus 0.651; P = 0.006, corrected P [P(corr)] = 0.036) and +1239C (0.377 versus 0.297; P = 0.00094, P(corr) = 0.0056) were significantly increased in the SLE patients compared with the controls. The presence of the associated allele in single or double dose conferred an odds ratio (OR) of 2.35 (95% confidence interval [95% CI] 1.38-4.02) for SNP -156 and an OR of 1.57 (95% CI 1.16-2.13) for SNP +1239. These effects were independent of each other, i.e., not a consequence of linkage disequilibrium between the 2 alleles. The risk associated with a double dose of susceptibility alleles at both SNPs was 3.8-fold higher (95% CI 2.0-7.4) relative to the complete absence of susceptibility alleles. With regard to individual clinical and immunologic features, a significant association was seen between lymphadenopathy and -156 genotypes (overall P = 0.0011, P(corr) = 0.046). A significantly increased OPN serum level was detected in healthy individuals carrying +1239C (P = 0.002), which is indicative of an association between the SLE susceptibility allele and OPN levels.
These data suggest the independent effect of a promoter (-156) and a 3'-untranslated region (+1239) SNP in SLE susceptibility. We can speculate that these sequence variants (or others in perfect linkage disequilibrium) create a predisposition to high production of OPN, and that this in turn may confer susceptibility to SLE.
检测骨桥蛋白(OPN)基因多态性与系统性红斑狼疮(SLE)的关联。
采用变性高效液相色谱法扫描OPN基因编码区5'和3'侧翼区域的多态性。对394例意大利SLE患者和479例匹配对照进行病例对照关联研究。采用酶联免疫吸附测定法测定40例患者和124例对照的OPN血清水平,并比较不同OPN基因型之间的平均水平。
在检测到的13个单核苷酸多态性(SNP)中,与对照组相比,SLE患者中-156G等位基因(频率0.714对0.651;P = 0.006,校正P[P(corr)] = 0.036)和+1239C等位基因(0.377对0.297;P = 0.00094,P(corr) = 0.0056)显著增加。单剂量或双剂量携带相关等位基因时,SNP -156的比值比(OR)为2.35(95%置信区间[95%CI]1.38 - 4.02),SNP +1239的OR为1.57(95%CI 1.16 - 2.13)。这些效应相互独立,即不是两个等位基因之间连锁不平衡的结果。两个SNP位点双剂量携带易感等位基因的风险比完全不携带易感等位基因高3.8倍(95%CI 2.0 - 7.4)。关于个体临床和免疫特征,淋巴结病与-156基因型之间存在显著关联(总体P = 0.0011,P(corr) = 0.046)。携带+1239C的健康个体中检测到OPN血清水平显著升高(P = 0.002),这表明SLE易感等位基因与OPN水平之间存在关联。
这些数据表明启动子(-156)和3'非翻译区(+1239)SNP在SLE易感性中具有独立作用。我们可以推测这些序列变异(或处于完全连锁不平衡的其他变异)导致OPN高表达的易感性,进而可能赋予SLE易感性。